Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study on the Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

NCT00940862 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT00940862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00940862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study on the Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
August 31, 2011
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary atherosclerosis, psoriasis, vascular inflammation